Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taiwan Liposome Co. Ltd.

www.tlcbio.com

Latest From Taiwan Liposome Co. Ltd.

Biologics Blossoming: CANbridge Looks To Taiwan, WuXi Partners Juno

New policies including the allowance of contract manufacturing under a new marketing holder system are fast changing the nascent biologics sector in China, where the just 2% market penetration for such products is offering plenty of room for a new crop of startups including CANbridge to grow and thrive.

BioPharmaceutical China

Onxeo Plans Clinical Trials For Three Phase III Orphan Oncologics

The year-old pan-European biotech is targeting advanced liver cancer, severe mucositis and the rare cancer, peripheral T-cell lymphoma, for its first products in the orphan oncology niche.

BioPharmaceutical France

Carlina Develops Anticancer Nanocapsules For Pets And Patients

French drug delivery firm Carlina is developing new lipid-based nanoparticle formulations of cancer drugs for pets and patients, and aims to build a proprietary pipeline with the help of collaborations with other companies.

BioPharmaceutical France

China Looks Across Straits For New Drug Opportunities

A first-ever pharma collaboration signals strengthening links between asset-hungry Chinese drug makers and the burgeoning Taiwanese biotech sector.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Biotechnology
    • Liposomes
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Taiwan
  • Parent & Subsidiaries
  • Taiwan Liposome Co. Ltd.
  • Senior Management
  • Keelung Hong, Chmn. & CEO
    George Yeh, Pres.
    Yunlong Tseng, PhD, Dir., Research Dev.
    Cleo Pan, PhD, Dir., Preclinical
  • Contact Info
  • Taiwan Liposome Co. Ltd.
    Phone: 2 2655 7377
    11-F, 3 Yuang Street
    Nangang Dist.
    Taipei City,
    Taiwan
Advertisement
Advertisement
UsernamePublicRestriction

Register